Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01953926
Title Neratinib HER Mutation Basket Study (SUMMIT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Puma Biotechnology, Inc.
Indications

Advanced Solid Tumor

Therapies

Neratinib + Trastuzumab

Fulvestrant + Neratinib + Trastuzumab

Neratinib

Neratinib + Paclitaxel

Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | CAN | BEL | AUS

Additional content available in CKB BOOST